Eastman Chemical (EMN) Liabilities and Shareholders Equity (2016 - 2026)
Eastman Chemical (EMN) has disclosed Liabilities and Shareholders Equity for 18 consecutive years, with $15.2 billion as the latest value for Q1 2026.
- For Q1 2026, Liabilities and Shareholders Equity rose 1.68% year-over-year to $15.2 billion; the TTM value through Mar 2026 reached $60.3 billion, changed 0.15%, while the annual FY2025 figure was $14.9 billion, 2.33% down from the prior year.
- Liabilities and Shareholders Equity hit $15.2 billion in Q1 2026 for Eastman Chemical, up from $14.9 billion in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $15.8 billion in Q1 2022 and bottomed at $14.6 billion in Q3 2023.
- Average Liabilities and Shareholders Equity over 5 years is $15.0 billion, with a median of $15.0 billion recorded in 2025.
- Year-over-year, Liabilities and Shareholders Equity dropped 7.84% in 2022 and then grew 3.96% in 2024.
- Eastman Chemical's Liabilities and Shareholders Equity stood at $14.7 billion in 2022, then fell by 0.23% to $14.6 billion in 2023, then rose by 3.96% to $15.2 billion in 2024, then decreased by 2.33% to $14.9 billion in 2025, then rose by 2.44% to $15.2 billion in 2026.
- According to Business Quant data, Liabilities and Shareholders Equity over the past three periods came in at $15.2 billion, $14.9 billion, and $15.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.